-
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trialVelazquez EJ, Morrow DA, DeVore AD et al. -
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensusFarmakis D, Agostoni P, Baholli L et al.
-
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm SocietyKusumoto FM, Schoenfeld MH, Barrett C et al.
-
In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 yEM DeFilippis, HGC Van Spall.
-
Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patientsZacharias M1, Joffe S, Goldberg RJ et al.
-
Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF TrialMN Kosiborod, PJhund, KF Docherty et al.
-
Heart Failure With Preserved Ejection Fraction in the YoungJ Tromp , MR MacDonald, CSP Lam et al.
-
Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart FailureAS Bhatt, L Liang, AD DeVore et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
